Centre for Research on Biomolecular Interactions

Centre for Research on Biomolecular Interactions. It is a dedicated research hub within the University of Toronto focused on elucidating the fundamental physical and chemical principles governing interactions between biological molecules. The centre brings together interdisciplinary teams to study processes critical to cellular function, disease mechanisms, and drug discovery. Its work integrates advanced biophysical techniques with computational biology to create detailed models of molecular recognition and assembly.

Overview

Established in 2005, the centre operates as a core facility and collaborative nexus within the university's extensive life sciences network, which includes the Temerty Faculty of Medicine and the Faculty of Arts & Science. Its creation was spearheaded by prominent scientists like Lewis Kay, a pioneer in NMR spectroscopy, to address the growing need for specialized infrastructure in structural biology. The centre's laboratories are housed in the Medical Sciences Building on the St. George campus, providing proximity to related institutes such as the Donnelly Centre for Cellular and Biomolecular Research. This strategic location fosters a vibrant research culture that attracts postdoctoral fellows and graduate students from programs like Biochemistry and Molecular Genetics.

Research focus and facilities

The primary research focus is on quantifying and visualizing the dynamics of biomolecular complexes, including protein-protein interactions, protein-nucleic acid binding, and membrane protein assemblies. Scientists employ a suite of state-of-the-art technologies, such as surface plasmon resonance for measuring binding affinities, isothermal titration calorimetry for thermodynamic profiling, and cryo-electron microscopy for high-resolution structure determination. The facility also maintains a robust computational chemistry cluster for running molecular dynamics simulations and docking studies. This integrated approach allows researchers to dissect the mechanisms of enzymatic catalysis, signal transduction pathways, and the formation of pathological aggregates seen in diseases like Alzheimer's disease.

Key scientific contributions

Researchers affiliated with the centre have made several landmark contributions to the field. A major breakthrough involved mapping the transient interaction networks within the Spliceosome, a complex crucial for RNA splicing, published in the journal Nature. Another significant study detailed the allosteric regulation mechanisms in G protein-coupled receptors, providing a framework for designing novel therapeutics with help from the Structural Genomics Consortium. Work on amyloid beta peptide aggregation has yielded new models for neurodegeneration, influencing drug discovery efforts at Pfizer and Roche. The centre's methodologies have also been applied to understand host-pathogen interactions, particularly in the context of viral entry mechanisms for pathogens like Influenza A virus.

Organizational structure and leadership

The centre is governed by a steering committee composed of principal investigators from various departments, including Chemistry, Biochemistry, and Molecular Genetics. It is led by a director, currently Dr. Alistair Finch, a renowned expert in X-ray crystallography who previously held a research chair at the Hospital for Sick Children. Operational management is overseen by a scientific manager who coordinates access to core instruments and training for users. The research staff includes dedicated specialists in spectroscopy and data analysis, supporting the work of over thirty independent research groups. Funding is secured through competitive grants from the Natural Sciences and Engineering Research Council, the Canadian Institutes of Health Research, and partnerships with industry leaders like Amgen.

Collaborations and partnerships

The centre maintains extensive collaborative ties with both academic and industrial entities. Within the University of Toronto, it works closely with the Lunenfeld-Tanenbaum Research Institute and the Princess Margaret Cancer Centre on projects related to cancer biology. International partnerships include joint research programs with the European Molecular Biology Laboratory and the Riken institute in Japan. A longstanding collaboration with GlaxoSmithKline focuses on fragment-based drug discovery for infectious diseases. The centre also participates in national networks like the Canadian Light Source synchrotron facility for macromolecular crystallography experiments. These partnerships ensure the translation of basic research on molecular interactions into applications for biotechnology and personalized medicine.

Category:Research institutes in Canada Category:University of Toronto Category:Biochemistry organizations Category:Scientific organizations established in 2005